Tag: biotech
Will Impact Investors Be Spared the Wrath of COVID-19?
Impact investors with money in sectors such as biotech, health and communications technology may see pandemic-fueled growth.
Forecasting models from a leading climate...
CRISPR Passes In-Human Safety Test, Showing Promise for Gene-Editing Tool’s ...
The gene-editing technique known as CRISPR was declared safe and feasible after a trial in cancer patients, potentially opening the door for...
Biotech Epirium Raises $85M With Aim to Develop Anti-aging Technology
It may be the final frontier in medicine -- slowing down or reversing the process of aging. Besides the promise of a...
Investors Seeing Green With Bets on Ag Biotech, as Key to...
As the farm industry sparks worries about everything from genetically modified food to climate change, impact investors are increasingly betting on a...
Biotech Novoheart to Collaborate With AstraZeneca on Heart-in-a-Jar Model
Stem cell biotech company Novoheart and pharmaceutical giant AstraZeneca announced they would be partnering to develop the first test tube model of...
Google’s Porat Sees AI as Weapon in Breast Cancer War, as...
Google says it wants to be more than just a search engine for breast-cancer patients -- a point CFO Ruth Porat makes...
Alphabet, Amazon and Apple Push Hard into Healthcare, Leveraging Digital and...
Key Takeaway: The world’s biggest tech firms, including Alphabet, Amazon and Apple,...
Color Adds Counseling to Genetic Services, With Eye Toward Better Healthcare...
As sales of consumer genetic tests slow amid rising privacy concerns, Color Genomics has chosen a different path, by focusing on counseling...
Vasopharm to Sell Drug for Traumatic Brain Injury, An Overlooked Killer
Germany’s Vasopharm raised $10.7 million as it plans to submit data for a clinical trial next year for its product that seeks...
Eisai Tries to Bounce Back With New Dementia Approach
Eisai Inc. opened an incubator for research into Alzheimer’s and other diseases as part of its new dementia research center, as it...
BioNTech, Melding AI, Robotics and Biotech, Nets $325 Million for Vaccine...
German start-up BioNTech raised $325 million in private funding, one of the largest hauls for a European biopharma company, which will help...
The Specter of Theranos Is Haunting Biotech Startups
The final chapter in Elizabeth Holmes’ story as an entrepreneur is set to begin next year with her fraud trial scheduled for...
Biotech Startup Is Vying to Improve Memory Through Brain Implants
If Nia Therapeutics succeeds, brain chips will enter medical clinics in three years that will provide memory generation for all patients suffering...
Russian Scientist Plans Gene-Edited Baby Following Chinese Experiment
On Our Radar: Deals we are paying attention to, for their impact on industry
Russian scientist Denis Rebrikov told...
Sequoia and Highlight Give Cullgen $16M in Series A Financing
On Our Radar: Deals we are paying attention to for their impact on industry.
Biotech firm Cullgen’s April 10 announcement that it had received a...
Christian Bailey: “I realized there wasn’t someone connecting the solutions that...
Sound Businesses: Profiles of companies and business models we are keeping an eye on.
Skin cancer is the most commonly diagnosed cancer in America, with...
SpringWorks Therapeutics Scores $125M in Series B Financing Through Perceptive Advisors
On Our Radar: Deals we are paying attention to for their impact on industry.
Clinical-stage biopharmaceutical company SpringWorks Therapeutics, Inc. moved closer on April 1 to advancing...
Thermo Fisher Scientific Gets Serious About Gene Therapy with Brammer Bio...
On Our Radar: Deals we are paying attention to for their impact on industry.
Thermo Fisher Scientific, the world’s biggest manufacturer of scientific instruments, bid...